about
Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity.Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk.Dietary polyunsaturated fatty acids and colorectal neoplasia.Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cellsImmune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathwaysThe involvement of endoplasmic reticulum stress in the suppression of colorectal tumorigenesis by tolfenamic acid.Review paper: Cancer chemopreventive compounds and canine cancer.A novel intradural extramedullary spinal cord tumor in young dogs.Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.Zyflamend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer.Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK.Meningocerebral hemangiomatosis resembling Sturge-Weber disease in a horse.Selective inhibition of Delta-6 desaturase impedes intestinal tumorigenesis.Colorectal ganglioneuromatosis in a young female dog (Lhasa Apso).Large granular lymphocyte tumor in a horse.Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells.Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.Granulated round cell tumor of cats.Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors.Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene.Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice.Erythema multiforme associated with zonisamide in a dog.Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigensNonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasiaIntrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS IOcular lesions in canine mucopolysaccharidosis I and response to enzyme replacement therapy
P50
Q30499512-41B61817-7AFB-4229-9EED-2DA0538DACF7Q33851073-1C1A4971-CAF8-45CD-859F-313F8410D2A0Q34005906-7B339BB4-C205-4E8B-8C25-FB56E6ABE8E6Q34176627-8CBAB211-171A-473B-82D9-C06726C8A4F1Q34687656-140BD811-A6D2-45F8-9367-692FC97044B7Q35005048-EB5EFCD2-3B49-4F2B-BF0D-CE0A49A2D345Q35098895-C6B7410D-4C96-4B1A-BFF9-C5DFF41BFCA7Q36791066-EF750ECB-6F1B-4D40-B344-4C16152C6FD8Q37001526-B334F285-594E-41FB-869E-740FD709D690Q37374999-55194E91-7359-455E-B397-ACA670AAEE5FQ37411797-CFED6B03-E93C-4DFE-BF7D-CB5524F44D9FQ38187821-D3A07FD7-D73D-4656-88BA-A5A52C15E18DQ38512674-84754A0D-4C39-4910-8C37-564DAD83A8D7Q39337547-99612389-9D59-401D-AC82-A27BCB6A86EEQ39465959-DD00D95E-42BB-40DB-B25D-D78088221449Q40643465-336DE33B-033C-47B2-9EF0-45F67B8ED19AQ42524380-5901EC23-F0A6-48E6-8AB5-FC13C8D2C657Q43821507-C18F5E7E-DA69-4A0A-9518-E04F4FE30972Q43949312-39ACEFBD-5602-48FD-BE47-69FD9FADD905Q44860835-AADE5C83-C77A-495C-8254-92E645A8914CQ45016574-5ECEDEB1-E4E0-40D7-A637-97C7E97A1076Q46465779-8D1B82C1-7021-48D7-A478-7483DC1FE1DFQ50784404-BF16529A-45D0-4C60-856C-AAE3E201157CQ50947872-712F529E-6DA0-40DB-9472-46256DBBDD5DQ51023261-8EFF2F33-0014-4565-B30C-84EFECB80EC4Q51777700-D40658A0-339A-46EC-A096-5406BC4E5A1FQ53419108-2D290A4F-8CAE-4CF5-B8D5-AD9F56DA280EQ69008794-C7F31A6E-3093-4DFE-8CA1-D18E22CB18FFQ79353945-176D590E-F1C4-415A-882A-13DAFD97A8CAQ80820588-25905974-7283-4DED-89CB-20AEF611D47BQ83706710-DA7458DF-8121-45D8-9A2E-018E483708E7
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael F. McEntee
@ast
Michael F. McEntee
@en
Michael F. McEntee
@es
Michael F. McEntee
@nl
Michael F. McEntee
@sl
type
label
Michael F. McEntee
@ast
Michael F. McEntee
@en
Michael F. McEntee
@es
Michael F. McEntee
@nl
Michael F. McEntee
@sl
prefLabel
Michael F. McEntee
@ast
Michael F. McEntee
@en
Michael F. McEntee
@es
Michael F. McEntee
@nl
Michael F. McEntee
@sl
P106
P1153
7005873799
P21
P31
P496
0000-0002-1616-3715